Abstract
The safe and efficient use of herpes simplex virus (HSV)-based vectors to deliver genes of potentially therapeutic benefit to the central nervous system will require their effective disablement by the inactivation of viral genes required for lytic growth. Here we report that viruses lacking functional genes for ICP27 (which is required for growth in all cell types) and ICP34.5 (which is required for growth in nondividing cell types) can deliver a marker gene to both the rodent and primate CNS with high efficiency whilst producing relatively minimal damage and having no effect on sodium currents in dorsal root ganglion neurons. Such viruses paradoxically deliver genes at much higher efficiency than the less disabled single mutant lacking ICP34.5 alone and also, as expected, produce less damage in vivo. Moreover, unlike the single mutant lacking ICP27 the double mutant viruses cannot revert to wild-type by acquistion of complimenting gene sequences during growth of virus stocks in vitro on dividing cells expressing ICP27 since artificial expression of ICP34.5 in these cells is not required. Such ICP27−; ICP34.5− viruses thus offer a platform for the development of vectors which are sufficiently safe for ultimate use in human gene therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Howard, M., Kershaw, T., Gibb, B. et al. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5. Gene Ther 5, 1137–1147 (1998). https://doi.org/10.1038/sj.gt.3300700
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300700
Keywords
This article is cited by
-
RNA Interference with Special Reference to Combating Viruses of Crustacea
Indian Journal of Virology (2012)
-
Evaluation and optimization of the administration of a selectively replicating herpes simplex viral vector to the brain by convection-enhanced delivery
Cancer Gene Therapy (2011)
-
Animal Models for Target Diseases in Gene Therapy — using DNA and siRNA Delivery Strategies
Pharmaceutical Research (2009)
-
Neuroprotective Effects of Virally Delivered HSPs in Experimental Stroke
Journal of Cerebral Blood Flow & Metabolism (2006)
-
Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids
Gene Therapy (2004)